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The role of complement in infections by dermatophytes 
is unknown. Therefore we evaluated the ability of the 
dermatophyte Trichophyton rubrum to activate comple-
ment in vitro. Aliquots of human plasma that had b een 
incubated with T. rubrum were examined for evidence 
of complement activation. Following incubation, the to-
tal hemolytic complement activity of plasma fell 76%. 
Further, each T. rubrum incubation le d to obvious C3 
conversion and generation of polymorphonuclear leu-
kocyte (PMN) aggregating activity. Plasma that had 
complement activity depleted by h eat (56 °C x 30 min) or 
10 mM EDTA failed to develop C3 conversion or PMN 
aggregating activity. Complement activation was not 
affected when the classical complement pathway was 
selectively blocked by MgEGTA. These studies indicate 
that T. rubrum can activat e the complement system by 
the alternative pathway. The consequent generation of 
anaphylatoxins, chemotaxins, and opsonins might be 
important both in host d efense against dermatophytic 
infections and in the inflammatory reactions mediated 
by them. 
The immune a nd inflammatory systems of the body play a 
major role in the clin ical manifestations of dermatophytic in-
fections. While several branches of th ese systems [1,2] are 
known to be important in infections by dermatophytic fungi, 
t he interactions between complement a nd this group of orga-
nisms is unknown. The object of this study was to determine 
whether one of these fungi, Trichophyton rubrum, was capable 
of activating complement in vitro. 
MATERIALS AND METHODS 
Isolates of T. rubrum were identified by gross and microscopic 
examination and growth characteristics on special media. The fungus 
was grown in nu trient broth medium (DIFCO, Detroit, Michigan) to 
which 100 11g/ ml of streptomycin and 100 11g/ml of penicillin were 
added. The broth remaining after harvest 9f the fungus was free of 
bacteria as determined by culture. Heparinized fresh venous plasma 
was obtained from random normal donors. Heparin concentration was 
rigidly controLled (2 uni ts/ml) to avoid inhibition of alternative pathway 
complement activation [3]. Aliquots of the heparinized plasma were 
depleted of complement activi ty by heat (56°C X 30 min) or EDTA (10 
mM) , or had the classical pathway selectively blocked by the addition 
of MgEGTA (10 mM) [ 4]. These plasmas were then incubated as 
described below wilh (a) desiccated T . rubrum., (b) zymosan (as a 
positive control for complement activation) , (c) a saline blank, or (d) a 
sample of sterile culture broth. The fo llowing evidence of complement 
activation was then sought: (a) decrements in total hemolytic comple-
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ment (CHr.o), assayed by standard techniques [5], (b) C3 conversion, 
detected immunoelectrophoretically, and (c) the presence of C5a, as-
sayed as granu locyte aggregating activi ty [5-7]. 
Desiccated T . ru.bru.m was boiled in saline for 30 min, then resus-
pended in normal saline at a concentration of 20 mg/ml, as was 
commercially obtained zymosan (ICN Pharmaceuticals, Cincinnati, 
Ohio) . One volume of zymosan or T. ru.brum suspension was then 
added to 9 vol of plasma and incubated (37°C x 30 min) with agitation; 
the zymosan or T. rubrum. was then removed by centrifugation and the 
plasma aliquots frozen at -70°C until complement assays were per-
formed. All assays were per formed within 1 week of incubation. In 
paraLlel, like volu mes of normal saline or of a 1:10 dilution of culture 
broth in normal saline were incubated with the plasmas and were 
similarly assayed. 
C3 immunoelectrophoresis was carried out, modifying our previously 
described method [8] by using a Corning Model 700 IELP cell (Corning, 
Palo Alto, California) and commercially available agarose-mylar ftlms; 
verona! buffer (pH = 8.6, 11 = 0.05) was employed. To each sample was 
added 1/10 vol 100 mM disodium EDTA to prevent ar tifactual comple-
ment activation by the agarose film. 
Granulocytes (PMNs) for the aggregometric assay were harvested 
from venous blood of normal volunteers by our previously described 
[6] modification of the method of B0yum [9]. Plasmas from the test 
incubations were then used as test aggregants of the normal granulo-
cytes by adding 50 111 of plasma to 0.45 ml of granulocyte suspension 
(104 PMN/11!), stirring in an aggregometer, and recording the resulting 
change in light transmission [5-7,10). Such aggregating activi ty has 
been shown to be due to the presence of C5a (or of its desarginine 
derivative) and to be a sensitive indicator of complement activa-
tion [5]. 
RESULTS 
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Incubation of T. rubrum with normal plasma led to a mean 
decrement in CHr.o of 76.2% (± 5.8, SEM) (p < 0.01) . Parallel 
incubation with zymosan led in all cases to a greater than 95% 
decrement in CH r,o (different from both control and T. rubrum-
incubated plasma at p < 0.01) . Incubation with dilute sterile 
culture broth, estimated to exceed the maximal contamination 
of the system by broth by at least 10-fold, led to no decrem en t 
in CHr,0• 
As a more direct demonstration of complement activation, 
evidence of C3 conversion was sought immunoelectrophoreti-
cally. When C3 is activated, conversion products are formed 
which have an electrophoretic mobility different from that of 
intact C3. On immunoelectrophoresis, these may be visualized 
as a n arc displaced a nodally (Fig 1). These results were con-
cordant with those obtained by simply measuring hemolytic 
complement levels. That is, incubation with zymosan led to the 
development of a very dense arc of C3 conversion products. A 
similar arc was visible when plasma incubated with T . rubrum 
was tested . The broth failed to cause C3 conversion. 
Since the development of inflammation in response to com-
plement activation probably depends on the generation of C5a, 
the major complement ch emotaxin, we also tested the plasmas 
for the presence of C5a (Fig 2). 
In t he PMN aggregation assay, when a somce of activated 
complement is added to a suspension of granulocytes stirring in 
a n aggregometer, a n increasing wave of light transmission (~T) 
is seen, which has been shown to represent aggregation pro-
duced by the presence of C5a or its desarginine derivative in 
the sample. When plasma was incubated with zymosan, which 
is a fungal cell wall product known to be a potent activator of 
complement, it acquired th e a bility to aggregate granulocytes 
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FIG 1. Incubation of plasma with T. rubrum leads to C3 conversion. 
Photographs of immunoelectrophoretic gels. Troughs contain anti-C3 
antiserum; wells contain test plasmas. Top panel: Control plasmas. 
Center panel: Plasma incubated with zymosan to activate complement 
deliberately; arrowhead: a nodally displaced arc of C3 convers ion prod-
ucts. Lower panel: Plasma incubated with T. rubnun, with a simila r 
convers ion arc. The troughs and wells have been out lined for clarity. ~ . "*-~ ()!"\ Plasma mcubated w1th : 
J~/ Zymosan 
T rubrum 
LH 
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FIG 2. Incubation of T. rubrum with plasma generates C5a- related 
granulocyte aggregating activity. Vertical axis is an arbitrary scale of 
light transmission (tJ.T); horizonta l axis depicts time. Zymosan-acti-
vated plasma (top) and T. rubrwn-incubated plasma (center) aggregate 
PMNs, while plasma incubated with culture broth (bottom) produces 
only a dilution artifact. 
quite potently. The incubation of clinical isolates ofT. rubrum 
with plasma Jed to a similar development of aggregating activ-
ity. The incubation of a saline blank or culture broth control 
with plasma caused no aggregating activity; such plasmas pro-
duced only a dilution artifact when added to granulocytes. 
Plasmas depleted of complement activity by heat or EDT A 
produced tracings similar to that of the control. In contrast, 
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plasma that had been treated with MgEGTA before T. rubrum 
incubation allowed such aggregating activity to develop and 
indeed allowed C3 conversion to occur. This suggests that t he 
presence of an intact alternative complement pathway is ade-
quate to allow activation to proceed. 
DISCUSSION 
Complement plays critical roles in tissue inflammation and 
defense against various microbial invaders. Although it has 
been shown that complement is activated by a variety of fungi 
including Candida albicans [11], Saccharomyces spp [12], and 
others [13,14], the interaction between dermatophytes and com-
plement has remained largely unexplored. 
In this study we have shown that T. rubrum is a potent 
activator of the complement system. This was demonstrated by 
a decrement in CH5o, conversion of C3, and generation of 
granulocyte aggregating activity (C5a) in plasma exposed to 
this fungus. However, T . rubrum appeared to be a somewhat 
less potent activator than zymosan, a derivative of Saccharo-
myces cell walls. That is, the decrement in CHr.o produced by 
zymosan was greater than that by an equal mass (though not 
necessarily an equal surface area) of T. rubrum. 
The generation of granulocyte aggregating activity was 
cleru·ly complement dependent, since such aggregation was 
prevented when complement-depleted plasma was used as sub-
strate. The CHr,o and C3 conversion assays ru·e complement 
dependent by definition. 
The activation of complement appeared to proceed primarily 
along the alternative pathway. The presence of MgEGTA, a 
selective blocker of the classical pathway [ 4], usually did not 
attenuate the development of granulocyte aggregating activity 
or C3 conversion. On the other hand, complement was activated 
to a somewhat Jesser degree in MgE"GTA:-treated plasma from 
o~al d1Jriors, suggestmg that some persons might have 
h1genough titers of complement-fixing antibodies directed 
against T. rubrum to amplify the complement activation when 
the classical pathway is allowed to function normally. This is 
not sm·prising since a similar pattern was observed with zymo-
san. 
Complement activation is unlikely to have occurred from 
bacterial contamination of the preparation because the fungus 
was grown in the presence of antibacterial agents and the 
supernatant culture medium was sterile on bacterial culture. * 
lf complement is activated by the dermatophyte T. rubrum, 
what role might be played by complement in producing inflam-
mation and defending against this organism? A working hy-
pothesis has been proposed by Jones et al to desc1·ibe defense 
against dermatophytosis [15]. Dming an incubation phase, an-
tigens from the organism penetrate into or through the epider-
mis and elicit aT lymphocyte-mediated response. This response 
produces a disruption of the epidermal bruTier allowing serum 
containing "serum dermatophyte inhibitory factor" to enter the 
stratum corneum. The dermatophyte, thus inhibited, is shed 
from the skin by desquamation. 
"Serum inhibitory factor" has been shown to be the iron-
binding protein transferrin, which inhibits the fungus by che-
lating iron needed for the organism's growth [16]. Whether 
complement activation by a dermatophyte results in inhibition 
of its growth in vivo remains to be determined. 
Complement activation could also contribute to the inflam-
mation which often accompanies clinical infection. Jones et al 
[15] applied T. m.entagrophytes spores to normal skin of non-
immune volunteers. After occlusion for 4 days, the ru·ea was 
mildly to moderately inflamed. Inflammation then decreased 
but later increased coincident with conversion of 48-h intrader-
mal trichophytin skin tests from negative to positive. The initial 
inflanunatory phase was attributed to an "irritant reaction." 
We suggest that this early inflammatory phase may have been 
mediated by complement activated by the dermatophyte. 
Some patients have a mildly inflamed, widespread dermato-
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phyte infection but negative 48-h trichophytin skin test reac-
t ions. Mechanisms causing this mild degree of inflammation are 
unknown. Ongoing, nonimmune activation of complement 
through the alternative pathway could evoke such a low-grade 
inflammatory response in these patients. 
In summary, in this study we have shown that T. rubrum 
activates complement primarily by the alternative pathway. 
The status of the interaction between other dermatophytes and 
complement is not known. We suggest that complement may 
play a role in the inflammatory states seen in infections with T. 
rubrum and that this inflammation may play a role, although 
perhaps not the major one, in defense against this organism. 
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The Role of UVB Radiation in the Induction and Elicitation of 
Photocontact Hypersensitivity to TCSA in the Mouse 
RICHARD D. G RANSTEIN , M .D., * WARWICK L . MORISON, M.D. , AND MARGARET L. KRIPKE, PH.D. 
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Photocontact hypersensitivity (PHS) to 3,3',4',5 te -
trachlorosalicylanilide (TCSA) can be induced in mice 
by using cyclophosphamide as an immunopotentiator. 
Only UV A (320-400 nm) radiation was required for both 
sensitization and elicitation of PHS. The reaction was 
successfully transferred to syngeneic mice by injecting 
them with lymph node cells from sensitized donors, a 
finding that demonstrates the immunologic nature o.f 
PHS. The presence of UVB (280-320 nm) radiation was 
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not necessary for sensitization and did not increase PHS 
beyond the levels observed with UV A radiation alone. 
Ultraviolet radiation in the UVB range (plus a small 
amount of UV A radiation) from FS40 sunlamps in the 
dose employed did not induce statistically significant 
PHS to TCSA, nor did it elicit a significant response in 
mice sensitized with TCSA plus UV A radiation. How-
ever, treatment of mice with UVB radiation at a distant 
site 6 days before sensitization suppressed the induction 
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